Revelation Financial Statements From 2010 to 2026

REVBW Stock  USD 0.01  0  15.85%   
Revelation Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Revelation Biosciences' valuation are provided below:
Earnings Share
(4.77)
There are over one hundred one available trending fundamental ratios for Revelation Biosciences, which can be analyzed over time and compared to other ratios. All traders should should check out Revelation Biosciences' recent fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Market Cap is likely to drop to about 4.1 M in 2026. Enterprise Value is likely to climb to about (3 M) in 2026
Check Revelation Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revelation Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.1 K, Other Operating Expenses of 7.3 M or Total Operating Expenses of 7.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.76. Revelation financial statements analysis is a perfect complement when working with Revelation Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Revelation Stock
Check out the analysis of Revelation Biosciences Correlation against competitors.
For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.

Revelation Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.7 M7.6 M2.6 M
Slightly volatile
Other Current LiabilitiesM1.3 M865.1 K
Slightly volatile
Total Current Liabilities2.8 M2.2 M1.2 M
Slightly volatile
Non Current Assets Total48.2 K50.7 K4.4 M
Pretty Stable
Common Stock Shares Outstanding207.1 K197.2 K36.1 K
Slightly volatile
Liabilities And Stockholders Equity5.7 M7.6 M2.6 M
Slightly volatile
Total Liabilities2.8 M2.2 M1.2 M
Slightly volatile
Accounts Payable915.2 K901.2 K860.9 K
Very volatile
Cash6.5 M7.5 M5.2 M
Slightly volatile
Cash And Short Term Investments6.5 M7.5 M5.2 M
Slightly volatile
Short Term Investments7.8 B7.5 B2.4 B
Slightly volatile
Other Current Assets57 K60 K144.6 K
Very volatile
Other Stockholder Equity27.2 M52 M15.2 M
Slightly volatile
Total Current Assets6.7 M7.6 M5.4 M
Slightly volatile
Capital Stock446470703.1 K
Very volatile
Common Stock6474701.7 K
Slightly volatile
Short and Long Term Debt Total13.4 K15.1 K16.5 K
Slightly volatile
Short Term Debt3.5 M3.3 M929.3 K
Slightly volatile
Current Deferred Revenue2.3 M2.6 M2.9 M
Slightly volatile

Revelation Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization36.1 K25.1 K110.5 K
Slightly volatile
Other Operating Expenses7.3 M9.2 M3.3 M
Slightly volatile
Total Operating Expenses7.3 M9.2 M3.3 M
Slightly volatile
Selling General Administrative4.3 M5.1 M1.8 M
Slightly volatile
Selling And Marketing Expenses21.4 K22.5 K101.8 K
Slightly volatile
Research Development4.4 M4.1 M1.7 M
Slightly volatile
Interest Expense30.7 K31.5 K39.3 K
Slightly volatile
Cost Of Revenue32.4 K25.1 K57.7 K
Slightly volatile
Reconciled Depreciation26.1 K32.1 K19.9 K
Slightly volatile

Revelation Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow5.6 M5.8 M45.8 M
Slightly volatile
Stock Based Compensation182.5 K152 K112.5 K
Slightly volatile
Begin Period Cash Flow15.6 M10.8 M50.9 M
Slightly volatile
Total Cash From Financing Activities19.9 M11.6 M52.8 M
Slightly volatile
Depreciation26.1 K32.1 K19.9 K
Slightly volatile
Issuance Of Capital Stock7.8 M4.9 M8.2 M
Very volatile
Dividends Paid6.1 M6.9 M7.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables656.5 K964.6 K607.4 K
Slightly volatile
Capex To Depreciation0.750.795.7624
Slightly volatile
Cash Per Share41.443.5816.6 K
Slightly volatile
Income Quality1.041.13.9624
Slightly volatile
Net Debt To EBITDA0.560.740.3092
Slightly volatile
Current Ratio1.853.093.2182
Slightly volatile
Capex Per Share0.09560.113.2565
Pretty Stable
Interest Debt Per Share79.6689.6297.8218
Slightly volatile
Debt To Assets0.00660.00740.0081
Slightly volatile
Ebt Per Ebit1.781.71.0811
Slightly volatile
Quick Ratio1.853.093.2182
Slightly volatile
Cash Ratio1.773.063.1199
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9832
Slightly volatile
Debt Ratio0.00660.00740.0081
Slightly volatile

Revelation Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.1 M4.4 M61.9 M
Slightly volatile

Revelation Fundamental Market Drivers

About Revelation Biosciences Financial Statements

Revelation Biosciences investors use historical fundamental indicators, such as Revelation Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revelation Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.6 M2.3 M
Cost Of Revenue25.1 K32.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revelation Stock Analysis

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.